Presencia de anticuerpos contra neurorreceptores cardiacos de acetilcolina muscarínicos tipo II en pacientes con enfermedad de Chagas e implantación de marcapasos

Tovar, Nubia Catalina; Echeverry, María Clara; Mora, Guillermo.
Biomédica (Bogotá) ; 29(3): 476-484, sept. 2009. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-544529

Documentos relacionados

  1. Non-neuronal Cholinergic Muscarinic Acetylcholine Receptors in the Regulation of Immune Function.
  2. No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients.
  3. Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results.
  4. RGS3L allows for an M<sub>2</sub> muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes.
  5. A parasympathetic neurotransmitter induces myoepithelial cell differentiation during salivary gland development.
  6. Spatiotemporal role of muscarinic signaling in early chick development: exposure to cholinomimetic agents by a mathematical model.
  7. Association of autoantibodies to muscarinic acetylcholine receptors with gastrointestinal symptoms and disease severity in patients with postural orthostatic tachycardia syndrome.
  8. Development of a Selective and High Affinity Radioligand, [<sup>3</sup>H]VU6013720, for the M<sub>4</sub> Muscarinic Receptor.
  9. Evaluación del UMELISA CHAGAS® con la incorporación de nuevos péptidos monoméricos y quiméricos representativos de diferentes regiones de Trypanosoma cruzi
  10. Developmental age and biological sex influence muscarinic receptor function and neuron morphology within layer VI of the medial prefrontal cortex.